Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants

Yan Li, Tongtong Zhang, Jing Zhang, Wenbin Li, Pei Yuan, Puyuan Xing, Zhou Zhang, Shannon Chuai, Junling Li, Jianming Ying*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology